Ergoteles’s VolitionRx Ltd VNRX Stock Holding History

Ergoteles’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-795	Closed	-$50K	–	1654
2021 Q4	$50K	Sell	795 -5,910	-88%	-$403K	﹤0.01%	1180
2021 Q3	$416K	Sell	6,705 -45	-0.7%	-$2.85K	0.02%	665
2021 Q2	$444K	Buy	+6,750	New	+$457K	0.01%	871

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ergoteles's VNRX Position: Q1 2022 in Review

Ergoteles sold out of VolitionRx Ltd (VNRX) in Q1 2022, closing a stake of 795 shares — an estimated $50K sold.

Ergoteles first reported a position in VNRX in Q2 2021 and held it in 3 quarters. The position peaked at $444K in Q2 2021. 34 funds tracked by Wall St. Rank hold VNRX as of Q1 2022.

Ergoteles reported no remaining VolitionRx Ltd position as of Q1 2022 after selling out during the quarter.
Ergoteles sold 795 VolitionRx Ltd shares in Q1 2022, an estimated $50K.
Ergoteles first reported a position in VolitionRx Ltd in Q2 2021 and held it in 3 quarters.
Ergoteles's VolitionRx Ltd position peaked at $444K in Q2 2021.
34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.